about
Neuroprotection for ischemic stroke: past, present and futureTreating Negative Symptoms in Schizophrenia: an UpdateThe role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectivesCiticoline in addictive disorders: a review of the literatureNeuroprotective properties of citicoline: facts, doubts and unresolved issuesTherapies targeting lipid peroxidation in traumatic brain injuryGlycerophospholipid Biosynthetic PathwayThe citicoline brain injury treatment (COBRIT) trial: design and methods.Eight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adults.Treatment of post-traumatic cognitive impairments.Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.Metabolomics Analysis of the Larval Head of the Silkworm, Bombyx moriEffectiveness of the addition of citicoline to patching in the treatment of amblyopia around visual maturity: a randomized controlled trial.The efficacy of citroline in the treatment of ischemic stroke and primary hypertensive intracereral hemorrhage; a review article.Effects of Resveratrol against Lung Cancer: In Vitro and In Vivo Studies.Resveratrol Prevents Tumor Growth and Metastasis by Inhibiting Lymphangiogenesis and M2 Macrophage Activation and Differentiation in Tumor-associated Macrophages.
P2860
Q24645185-95915DCE-1BC1-4273-A480-B44E2C36A193Q26744805-493A6135-98C9-454F-BF0F-5F0EA8F5C797Q26781186-10D67BE3-BCC3-4D63-9689-25D189323A29Q27014895-D7F1134D-4062-4A22-8F6F-5130F7924D11Q27021189-EEB8E884-D64D-4191-99F3-EDAB8F2266C0Q28394424-7D0B2452-DECD-45D2-91E5-691C82801869Q30230798-6F93F993-9CDF-487A-A8C9-B73F3B1F93CCQ33666576-CA84140B-5E19-480C-BA81-9FF9CCAD8DF2Q34852058-2CC06558-D64B-45AD-BC51-31708EE61ECAQ36220948-389B184D-861A-4309-AB35-C43412705A24Q36600438-69287E9C-76D6-4506-AEBE-F512CE8BB21CQ37196141-CBB8C425-767A-4517-8CD8-B16423B1C785Q37286414-5C546F1B-8E1B-4659-85E8-E0133CC1A0E2Q37733419-14E63C53-BF37-4EE5-B128-CD342702816AQ38009314-924583CC-A106-4F7A-8C95-3436E2E39B6AQ47123664-8C509F09-C016-486C-8043-A2050CCDD4EAQ52871399-9EF85EE9-FC01-4865-9F09-D65C2779E91F
P2860
description
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im Oktober 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/10/01)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/10/01)
@nl
наукова стаття, опублікована в жовтні 1995
@uk
مقالة علمية (نشرت في أكتوبر 1995)
@ar
name
CDP-choline: pharmacological and clinical review
@ast
CDP-choline: pharmacological and clinical review
@en
CDP-choline: pharmacological and clinical review
@nl
type
label
CDP-choline: pharmacological and clinical review
@ast
CDP-choline: pharmacological and clinical review
@en
CDP-choline: pharmacological and clinical review
@nl
prefLabel
CDP-choline: pharmacological and clinical review
@ast
CDP-choline: pharmacological and clinical review
@en
CDP-choline: pharmacological and clinical review
@nl
P3181
P1476
CDP-choline: pharmacological and clinical review
@en
P2093
G. Frontera
J. J. Secades
P3181
P356
10.1358/MF.2003.25.4.727207
P478
17 Suppl B
P577
1995-10-01T00:00:00Z